Le Lézard
Classified in: Health, Business
Subjects: NPT, CHI, FOR, AVO

Human Rights Group Criticizes Proposal to Continue African Circumcision Program with Adolescents as Violating Children's Rights

BERKELEY, Calif., Dec. 13, 2019 /PRNewswire-PRWeb/ -- The human rights group Attorneys for the Rights of the Child (ARC) (http://www.arclaw.org) has today criticized a proposal to continue the so-called voluntary medical male circumcision (VMMC) program in Africa, though only on boys mostly 15 years of age and older. The proposal was made in draft guidelines released in late November 2019 (https://www.state.gov/wp-content/uploads/2019/11/2019-11-25-COP20-Guidance-Full-Consolidated_Public-2-1.pdf) by the US President's Emergency Plan for AIDS Relief (PEPFAR). ARC claims that as applied to youths 15 years of age and older, Section of the guidelines, focusing on VMMC, unconscionably distort medical evidence and violate medical ethics and federal law, not to mention basic economics.

ARC Executive Director J. Steven Svoboda said in a comment ARC co-submitted today to PEPFAR that circumcision is not the most cost-effective way to reduce males' risk of HIV acquisition. He commented, "The VMMC program has failed in its goal to circumcise Africa despite advertising and other publicity that his misled African youths into thinking circumcision is a safeguard from contracting HIV." ARC co-submitted its comments with colleagues Antony Lempert, M.D. and Michel Garenne, Ph.D.

At the same time, Svoboda expressed ARC's appreciation for the guidelines' recommendation that the VMMC program be discontinued for most African youths 14 years of age and younger.

Svoboda said, "Regarding those 15 years of age and older, the most critical aspects of the guidelines lie in what PEPFAR leaves out. A basic principle of medicine described in the Hippocratic Oath requires that all doctors, 'Do no harm.' Medical ethics require doctors to use the most effective, least invasive treatment for any condition. For HIV prevention, this remains condoms."

Svoboda stated, "The time is right to stop this ill-conceived, Western-centric program. We call on the guidelines to cancel the VMMC program for all ages before further harm occurs and to divert the funds that are thereby saved to programs of proven effectiveness. The law and medical ethics require no less."

The world HIV crisis is now under control and HIV is considered a chronic illness. Thus the emergency mentality that has in the past driven the VMMC program is no longer needed and indeed, is overridden by paramount ethical and legal principles. Amputating healthy body parts in a misguided attempt to stop it is a massive misdirection of effort, particularly when those body parts are taken from people not providing fully informed consent. VMMC participants were not properly informed that circumcision does not completely protect anybody, but at most reduces the probability of transmission, which is quite different.

Attorneys for the Rights of the Child is a non-profit organization founded in 1997 to protect children from unnecessary medical procedures to which they do not consent. ARC is currently working with the United Nations in response to UN requests for its expertise regarding human rights law.


SOURCE Attorneys for the Rights of the Child

These press releases may also interest you

at 12:57
Brooks Life Sciences expansion of Indianapolis facilities strengthens the company's capability in biobanking and sample management. This expansion will bring significant benefits for clients in academia and pharma who are...

at 12:45
The "Diarrhea - Pipeline Review, H1 2020" drug pipelines has been added to ResearchAndMarkets.com's offering. This report provides an overview of the Diarrhea (Gastrointestinal) pipeline landscape.The Pharmaceutical and Healthcare latest pipeline...

at 12:39
Oncopeptides AB announces today that it will host a webcast at 11am (CET) on Monday, January 27th 2020 where CEO Jakob Lindberg will present and explain melflufen's mechanism of action. Conference call for investors, analysts and the media, Monday,...

at 12:37
Koneksa Health, the leader in developing and implementing patient-focused digital biomarkers for drug development, along with Merck & Co, Inc. announced the publication of a peer-reviewed Phase I clinical trial evaluating the accuracy and...

at 12:31
(Family Features) While family history and age cannot be changed, there are everyday steps men can follow to take charge of their health, including prostate health, and maybe even prevent problems down the road. Consider...

at 12:30
The "2020 Japan Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: Supplier Shares by Country and Segment Forecasts, Emerging Technologies, Competitive Strategies" report has been added to ResearchAndMarkets.com's...

News published on 13 december 2019 at 18:30 and distributed by: